| Literature DB >> 34098081 |
Scott J Barraza1, Janice A Sindac1, Craig J Dobry2, Philip C Delekta2, Pil H Lee3, David J Miller2, Scott D Larsen4.
Abstract
We have previously reported the development of indole-based CNS-active antivirals for the treatment of neurotropic alphavirus infection, but further optimization is impeded by a lack of knowledge of the molecular target and binding site. Herein we describe the design, synthesis and evaluation of a series of conformationally restricted analogues with the dual objectives of improving potency/selectivity and identifying the most bioactive conformation. Although this campaign was only modestly successful at improving potency, the sharply defined SAR of the rigid analogs enabled the definition of a three-dimensional pharmacophore, which we believe will be of value in further analog design and virtual screening for alternative antiviral leads.Entities:
Keywords: Antiviral; Conformationally restricted; Neurotropic alphavirus; Pharmacophore; Western equine encephalitis virus
Mesh:
Substances:
Year: 2021 PMID: 34098081 PMCID: PMC8272561 DOI: 10.1016/j.bmcl.2021.128171
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.940